Want to Join Our Team?
Learn about Blue Matter's innovative work experiences, enriching development opportunities, team-oriented "People First" culture, and a lot more.
Insights
Access our ever-expanding library of thought leadership resources for strategic leaders and professionals in biopharma. It’s full of useful content addressing industry challenges, best practices, therapeutic markets, innovative ideas, and forward-looking insights.
Featured eBook
The “Best Practice Organization” and Its Importance for Success in Today’s Biopharma Industry
Learn More >
Whitepaper
The Joint Clinical Assessment: Expectations and Strategic Implications
Blog
Surveying the Shifting Landscape in European Market Access (Part 3: The JCA – Expectations and Strategic Implications)
Blog
Surveying the Shifting Landscape in European Market Access (Part 2: Changes for Orphan Drugs)
Blog
Surveying the Shifting Landscape in European Market Access (Part 1)
Blog
August 2023 Roundup of HTA Decisions in Three Top European Markets and a Perspective on How to Sustain a High ASMR Score at Reassessment by HAS
Blog
July 2023 Roundup of HTA Decisions in Oncology and a Perspective on the UK Cancer Drugs Fund (CDF)
Blog
Trends in European Healthcare Policy Will Continue to Shape Access to Healthcare in 2023
Blog
12 Pitfalls in Europe: Pitfall #8 – Failing to Realize that Early Access Programs (EAPs) Can Boost…or Bite
Blog
12 Pitfalls in Europe: Pitfall #6 – Missing the Mark with Local Health Technology Assessment (HTA)
Blog
12 Pitfalls in Europe: Pitfall #5 – Thinking your list price won’t cross borders
Presentation
Managed Entry Agreements: Overview and Outlook
Whitepaper
An Overview of Cross-Border Collaborations on HTA, Pricing Negotiation, & Procurement
Blog
An Overview of Cross-Border Collaborations on Healthcare Technology Assessment, Pricing Negotiation, and Procurement
Blog
Introducing our New Presentation Series on Access Evidence Generation
Presentation
Access Evidence Generation Series (Part 1): Surrogate Endpoints
Whitepaper
Five Trends to Watch in the European Market Access Environment
